Sökning: "oral glucose lowering drugs"

Hittade 4 avhandlingar innehållade orden oral glucose lowering drugs.

1. 1. Glucose-lowering interventions and risk assessment in patients with coronary heart disease and disturbed glucose metabolism

   Författare :Camilla Hage; Karolinska Institutet; Karolinska Institutet; []
   Nyckelord :;

   Sammanfattning : Background: Abnormal glucose regulation (AGR) including impaired glucose tolerance (IGT) and diabetes mellitus type 2 (T2DM) are common in patients with stable and unstable coronary artery disease (CAD) and impair their prognosis. Available glucose lowering interventions have not fully succeeded in improving the detrimental prognosis and accurate screening methods and new treatment strategies are needed. LÄS MER

3. 2. Diabetes mellitus in patients with coronary artery disease : cardiovascular risk assessment and impact of available treatments

   Författare :Matteo Anselmino; Karolinska Institutet; Karolinska Institutet; []
   Nyckelord :Coronary artery disease; diabetes; acute coronary syndromes; guidelines; prevention; evidence-based medications; revascularisation; insulin; oral glucose lowering drugs; risk stratification; artificial neural network;

   Sammanfattning : A majority of patients with coronary artery disease have abnormal glucose regulation and as many as 30% overt diabetes mellitus. Despite considerable improvements in the management of cardiovascular diseases, patients with diabetes have not benefited to the same extent as those without this disease. LÄS MER

4. 3. Dysglycaemia and cardiovascular disease. Aspects on screening, management, and prognosis

   Författare :Giulia Ferrannini; Karolinska Institutet; Karolinska Institutet; []
   Nyckelord :;

   Sammanfattning : Background: Dysglycaemia, in this thesis defined as impaired glucose tolerance (IGT) or type 2 diabetes (T2DM), is a major risk factor for cardiovascular disease (CVD). International guidelines recommend screening for dysglycaemia and target-driven lifestyle and pharmacological management in people with high cardiovascular (CV) risk or established CVD for both men and women. LÄS MER

5. 4. Aspects on gender, quality of life and diastolic function in patients with cardiovascular disease and type 2 diabetes

   Författare :Laura Venskutonyte; Karolinska Institutet; Karolinska Institutet; []
   Nyckelord :;

   Sammanfattning : Background: A majority of patients with type 2 diabetes mellitus (T2DM) suffer and die from a cardiovascular disease (CVD). Because of the increasing prevalence of diabetes, it today rivals smoking, hypertension and hypercholesterolemia as a major risk factor for CVD resulting in a need for more attention and further investigations. LÄS MER